Pesquisar
Translational Development Acquisition Corp
TDACAdicionar à lista de desejos
10.860USD
-0.020-0.18%
Fechamento 09-24 16:00（ET）
209.71MValor de mercado
38.33P/L TTM
Sobre o Translational Development Acquisition Corp Empresa
Translational Development Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The Company has neither engaged in any operations nor generated any revenues.
Translational Development Acquisition Corp Perfil
Código da empresaTDAC
Nome da EmpresaTranslational Development Acquisition Corp
Data de listagemDec 23, 2024
CEOHoffman (Michael B)
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalDec 23
Endereço52 E 83Rd St.
CidadeNEW YORK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal10028
Telefone14132042769
Site
Código da empresaTDAC
Data de listagemDec 23, 2024
CEOHoffman (Michael B)
Executivos da empresa Translational Development Acquisition Corp
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Michael B. Hoffman
Mr. Michael B. Hoffman
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Avanindra C. Das
Mr. Avanindra C. Das
Chief Financial Officer
Chief Financial Officer
--
--
Dr. E. Premkumar Reddy, Ph.D.
Dr. E. Premkumar Reddy, Ph.D.
Independent Director
Independent Director
--
--
Dr. Curtis T. Keith, Ph.D.
Dr. Curtis T. Keith, Ph.D.
Independent Director
Independent Director
--
--
Mr. Matthew A. Kestenbaum
Mr. Matthew A. Kestenbaum
Independent Director
Independent Director
--
--
Mr. Christopher Jarratt
Mr. Christopher Jarratt
Independent Director
Independent Director
--
--
Perguntas frequentes
Quem são os cinco principais acionistas de Translational Development Acquisition Corp?
Os cinco principais acionistas de Translational Development Acquisition Corp são: Mr. Michael B. Hoffman
Quantas instituições possuem ações da Translational Development Acquisition Corp (TDAC)?
Em 2026Q1, 54 instituições possuíam ações da Translational Development Acquisition Corp, com valor de mercado aproximado de 17.02M, representando 98.67% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -375852.00.